DOI: 10.1055/s-00034916

Nervenheilkunde

Referenz

James S. et al.
Comparison of ticagrelor, the first reversible oral P2Y(12) receptor antagonist, with clopidogrel in patients with acute coronary syndromes: Rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) trial.

Am Heart J 2009;
157: 599-605.

Bibliographische Angaben herunterladen

Aufrufen in:
Aufrufen in: